Not Yet RecruitingNCT07557121
Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration
PHASE2 · 35 planned enrolment
- Countries listed
- 0
- Registry update
- April 29, 2026
immortal.lifeTrial registrations containing the exact intervention label AIV007.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 35 planned enrolment
PHASE1 · 19 planned enrolment
PHASE1 · 3 planned enrolment